These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27763694)

  • 1. Feasibility of Defibrillation and Pacing Without Transvenous Leads in a Combined MICRA and S-ICD System Following Lead Extraction.
    Montgomery JA; Orton JM; Ellis CR
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):233-234. PubMed ID: 27763694
    [No Abstract]   [Full Text] [Related]  

  • 2. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New technologies of internal defibrillation.
    Dosdall DJ; Ideker RE
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():67-70. PubMed ID: 16133858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct recording of concealed ventricular extrasystoles producing pacer inhibition.
    Bowers M; Berger M
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1179-82. PubMed ID: 23600888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a crush: acute implantable cardioverter-defibrillator lead insulation break in a patient with multiple leads.
    Tilling L; Mason M
    Europace; 2014 Aug; 16(8):1196. PubMed ID: 25074973
    [No Abstract]   [Full Text] [Related]  

  • 6. Inappropriate shock because of triple counting in a patient with a subcutaneous implantable cardioverter defibrillator corrected by initiation of dual site left ventricular pacing.
    van Gelder BM; Bracke FA; Simmers T
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):239-40. PubMed ID: 25691559
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular Interventions in the Modern Age: The Million Dollar Man.
    Groves EM; Price MJ
    JACC Cardiovasc Interv; 2016 May; 9(10):1083-4. PubMed ID: 27131437
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of removal of a "dancing" Micra.
    Morani G; Bolzan B; Tomasi L; Vassanelli C
    Europace; 2017 Dec; 19(12):2000. PubMed ID: 28582502
    [No Abstract]   [Full Text] [Related]  

  • 9. Totally Leadless Dual-Device Implantation for Combined Spontaneous Ventricular Tachycardia Defibrillation and Pacemaker Function: A First Report.
    Ahmed FZ; Cunnington C; Motwani M; Zaidi AM
    Can J Cardiol; 2017 Aug; 33(8):1066.e5-1066.e7. PubMed ID: 28754393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How adequate are the current methods of lead extraction? A review of the efficiency and safety of transvenous lead extraction methods.
    Buiten MS; van der Heijden AC; Schalij MJ; van Erven L
    Europace; 2015 May; 17(5):689-700. PubMed ID: 25687745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable devices for the treatment of atrial fibrillation.
    Cooper JM; Katcher MS; Orlov MV
    N Engl J Med; 2002 Jun; 346(26):2062-8. PubMed ID: 12087143
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonpharmacological therapies for atrial fibrillation.
    Meshil MA; Bhakta D
    Cardiovasc Ther; 2010 Oct; 28(5):264-77. PubMed ID: 20626756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined therapy with transvenous cardioverter/defibrillator and anti-bradycardia pacemaker systems].
    Sticherling C; Klingenheben T; Skupin M; Li YG; Hohnloser SH
    Z Kardiol; 1997 Feb; 86(2):105-12. PubMed ID: 9173694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead extraction: The road to successful cardiac resynchronization therapy.
    Maciąg A; Syska P; Sterliński M; Przybylski A; Sitkowska E; Oręziak A; Bilińska M; Kuśmierczyk M; Szwed H
    Cardiol J; 2015; 22(2):188-93. PubMed ID: 25299498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations.
    Kosiuk J; Koutalas E; Doering M; Sommer P; Rolf S; Breithardt OA; Nedios S; Dinov B; Hindricks G; Richter S; Bollmann A
    Europace; 2014 Jul; 16(7):1028-32. PubMed ID: 24489073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experience.
    Deckx S; Marynissen T; Rega F; Ector J; Nuyens D; Heidbuchel H; Willems R
    Europace; 2014 Aug; 16(8):1218-25. PubMed ID: 24569572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leadless pacemaker use in a patient with a durable left ventricular assist device.
    Parker AM; Vilaro JR; Aranda JM; Al-Ani M; George P; Ahmed MM
    Pacing Clin Electrophysiol; 2020 Sep; 43(9):1048-1050. PubMed ID: 32394443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead extraction is preferred for lead revisions and system upgrades: when less is more.
    Maytin M; Epstein LM; Henrikson CA
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):413-24; discussion 424. PubMed ID: 20716723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.